Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
Crossref DOI link: https://doi.org/10.1007/s00787-015-0718-0
Published Online: 2015-05-22
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagy, Peter
Häge, Alexander
Coghill, David R.
Caballero, Beatriz
Adeyi, Ben
Anderson, Colleen S.
Sikirica, Vanja
Cardo, Esther
License valid from 2015-05-22